![Robert McGarr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert McGarr
Corporate Officer/Principal bij
DIANTHUS THERAPEUTICS, INC.
Profiel
Robert McGarr is currently the Head of Program & Alliance Management at Dianthus Therapeutics, Inc. starting in 2023.
Prior to this, he worked as a Director at Alnylam Pharmaceuticals, Inc. and Alliance Management LLC.
Actieve functies van Robert McGarr
| Bedrijven | Functie | Begin |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Corporate Officer/Principal | 11-09-2023 |
Eerdere bekende functies van Robert McGarr
| Bedrijven | Functie | Einde |
|---|---|---|
Alliance Management LLC
 Alliance Management LLC Other Metals/MineralsNon-Energy Minerals Operates as a holding company whose subsidiary operates polymetallic mine | Directeur/Bestuurslid | - |
| ALNYLAM PHARMACEUTICALS, INC. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Alliance Management LLC
Alliance Management LLC Other Metals/MineralsNon-Energy Minerals Operates as a holding company whose subsidiary operates polymetallic mine | Non-Energy Minerals |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
Kies MarketScreener 
